Dishman Pharma Fact Sheet, Dishman Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Dishman Pharma Fact Sheet    (DHPH)


Revealed: How to Get Rich with Just 3 Stocks


Here is the latest financial fact sheet of Dishman Pharma. For more details, see the Dishman Pharma quarterly results and Dishman Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

DISHMAN PHARMA Price History

Price Rs 301.1
Mkt Cap Rs m 48,588
Vol '000 460.5
P/E X 25.1
P/CF X 17.3
EPS (TTM) Rs 12.0
% ch % 2.9
No. of shares m 161.39
% ch week % 3.5
% ch 1-mth % -2.4
% ch 12-mth % 96.4
52 week H/L Rs 346.3/127.6
(As on May 29, 2017 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

DISHMAN PHARMA Financials

No. of Mths
Year Ending
12
Mar-12
*
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
5-Yr Chart
Click to enlarge
DISHMAN PHARMA EQUITY SHARE DATA
High Rs107122107183374 
Low Rs35423983129 
Sales per share (Unadj.) Rs139.3157.7171.7196.9197.8 
Earnings per share (Unadj.) Rs7.012.413.514.821.2 
Diluted earnings per shareRs3.56.26.87.410.6 
Cash flow per share (Unadj.) Rs16.522.827.033.534.7 
Dividends per share (Unadj.) Rs1.201.201.202.002.00 
Adj. dividends per shareRs0.600.600.601.001.00 
Dividend yield (eoy) %1.71.51.61.50.8 
Book value per share (Unadj.) Rs115.3128.2146.4153.4179.9 
Adj. book value per shareRs57.764.173.276.789.9 
Shares outstanding (eoy) m80.6980.6980.6980.6980.69 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x0.50.50.40.71.3 
Avg P/E ratio x10.16.65.48.911.9 
P/CF ratio (eoy) x4.33.62.74.07.2 
Price / Book Value ratio x0.60.60.50.91.4 
Dividend payout %17.19.78.913.59.4 
Avg Mkt Cap Rs m5,7296,6175,90210,69120,306 
No. of employees `0001.01.10.90.90.8 
Total wages/salary Rs m2,9413,5094,1234,2325,355 
Avg. sales/employee Rs Th11,541.312,059.014,848.018,430.919,252.7 
Avg. wages/employee Rs Th3,019.63,326.24,419.44,909.66,459.5 
Avg. net profit/employee Rs Th582.8950.61,171.21,389.92,064.1 
DISHMAN PHARMA INCOME DATA
Net Sales Rs m11,24112,72213,85315,88715,961 
Other income Rs m129178249869265 
Total revenues Rs m11,37012,90014,10216,75716,226 
Gross profit Rs m2,2452,9013,3213,1284,103 
Depreciation Rs m7658381,0861,5071,091 
Interest Rs m729788921897944 
Profit before tax Rs m8791,4531,5641,5932,334 
Minority Interest Rs m00000 
Prior Period Items Rs m00001 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m312450471394624 
Profit after tax Rs m5681,0031,0931,1981,711 
Gross profit margin %20.022.824.019.725.7 
Effective tax rate %35.431.030.124.826.7 
Net profit margin %5.07.97.97.510.7 
DISHMAN PHARMA BALANCE SHEET DATA
Current assets Rs m6,2396,7338,24510,13511,018 
Current liabilities Rs m6,5477,1279,02811,0489,517 
Net working cap to sales %-2.7-3.1-5.7-5.79.4 
Current ratio x1.00.90.90.91.2 
Inventory Days Days8797112103110 
Debtors Days Days6121385035 
Net fixed assets Rs m14,39114,57915,71715,82716,304 
Share capital Rs m161161161161161 
"Free" reserves Rs m8,2259,05110,03111,16712,907 
Net worth Rs m9,30710,34511,81312,37814,516 
Long term debt Rs m5,1214,3364,1213,3024,189 
Total assets Rs m22,49022,91126,27728,08929,805 
Interest coverage x2.22.82.72.83.5 
Debt to equity ratio x0.60.40.30.30.3 
Sales to assets ratio x0.50.60.50.60.5 
Return on assets %5.87.87.77.58.9 
Return on equity %6.19.79.39.711.8 
Return on capital %11.115.315.615.917.5 
Exports to sales %30.328.327.822.624.8 
Imports to sales %7.24.76.35.63.7 
Exports (fob) Rs m3,4043,5953,8553,5983,956 
Imports (cif) Rs m806599869891596 
Fx inflow Rs m3,9744,2103,9664,5764,952 
Fx outflow Rs m905695954974697 
Net fx Rs m3,0693,5153,0113,6014,255 
DISHMAN PHARMA CASH FLOW
From Operations Rs m 1,536 1,651 3,445 2,937 2,786 
From Investments Rs m -1,040 -1,173 -2,568 -1,581 -1,529 
From Financial Activity Rs m -680 -502 -741 -1,420 -941 
Net Cashflow Rs m -185 -23 136 -64 316 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 61.4%
Foreign collaborators 0.0%
Indian inst/Mut Fund 3.7%
FIIs 12.7%
ADR/GDR 0.0%
Free float 22.1%
Shareholders 46,261
Pledged promoter(s) holding 35.8%
 

Company Information

REGD OFF Bhadr-Raj Chambers, Swastik Cross Road, Navrangpura, Ahmedabad - 380 009
E-MAIL tushar.shah@dishmangroup.com WEB www.dishmangroup.com
TELEPHONE (079) 2644 3053 FAX (079) 2642 0198
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Link Intime India, C13, Pannalal Silk Mills Comp., LBS Marg, Mumbai-78
AUDITOR Deloitte Haskins & Sells
CHM: Janmejay R. Vyas (MD) COMP SEC: Tushar D. Shah YEAR OF INC: 1983 BSE CODE: 532526 FV (Rs): 2 DIV YIELD (%): 0.3

More Pharmaceuticals Company Fact Sheets:   SANOFI INDIA  PANACEA BIOTECH  GSK PHARMA  SUVEN LIFESCIENCES  ORCHID PHARMA LTD  

Compare DISHMAN PHARMA With:   SANOFI INDIA  PANACEA BIOTECH  GSK PHARMA  SUVEN LIFESCIENCES  ORCHID PHARMA LTD  

Compare DISHMAN PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; RBI Keeps Repo Rate Unchanged at 4%(12:30 pm)

Share markets in India are presently trading on a positive note, after the RBI kept repo rate unchanged at 4%.

Views on news

Most Popular

These 5 Smallcaps Deserve a Place in Your Coffee Can Portfolio (Profit Hunter)

Jul 28, 2020

When it comes to quality stocks, doing less is more.

Before You Buy Your First Electric Vehicle Consider Buying this Stock (Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

Gold or Silver: Which One Should You Buy Now? (Fast Profits Daily)

Jul 24, 2020

Silver and gold are both vying for your attention. Which is the better trade today?

A Zero Loss Strategy that Also Maximizes Returns in Volatile Stock Markets Views On News (Views On News)

Jul 24, 2020

Here's how to never lose money in stock markets.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

TRACK DISHMAN PHARMA

  • Track your investment in DISHMAN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DISHMAN PHARMA

DISHMAN PHARMA - TTK HEALTHCARE COMPARISON

COMPARE DISHMAN PHARMA WITH

MARKET STATS